Conference Coverage
Conference Coverage
Adopting high-dose radiation vs. conventional after mastectomy could be ‘game changer’
The use of the higher-dose approach, known as hypofractionation, “resulted in fewer treatment breaks and less financial toxicity.”
Conference Coverage
SABR could defer systemic therapy in oligoprogressive breast cancer
“We found surprisingly that SABR delayed a change in therapy by 10 months, which is great for patients.”
Conference Coverage
Salvage option to replace transplant in r/r Hodgkin lymphoma?
“The findings suggest that children, adolescents, and young adults with low-risk relapsed classic Hodgkin lymphoma can be salvaged with low-...
Conference Coverage
Cervical cancer: Vaginal dilation linked to less stenosis after treatment
Sexual intercourse and dilator use may reduce risk of vaginal stenosis following treatment for cervical cancer.
Conference Coverage
Longer edoxaban may benefit cancer patients with distal DVT
“This is the first and only randomized trial to show the superiority of longer duration over shorter duration of anticoagulation therapy for...
Conference Coverage
Measures of PTH predict postthyroidectomy hypocalcemia
“This measure can serve as a guide for discharging patients the same day, with instructions to return if they develop any symptoms of hypocalcemia...
Conference Coverage
Triple therapy boosts anaplastic thyroid cancer survival
"The very long median overall survival in the study's neoadjuvant group is quite remarkable for a group of patients who used to have a very poor...
Conference Coverage
Therapeutic vaccine shows promise in treating lung cancer
“We realized that just half of patients really benefited from the vaccine: those who had previously responded to immunotherapy.”
Conference Coverage
Nivolumab/Ipillimumab combo demonstrates long-term efficacy in NSCLC
“Most importantly, approximately 50% of these patients that are alive at six years are also disease free, suggesting that we are indeed making a...
Conference Coverage
Proposed TNM update could shift staging for lung cancers
Lung cancers, particularly those with T1 disease, could be reclassified into a different overall stage if proposed adaptations to the N and M...
Conference Coverage
Neoadjuvant durvalumab does not affect surgical outcomes in NSCLC: Study
AEGEAN is one of the first studies looking at immune checkpoint inhibitors in the perioperative settings that demonstrated improved EFS and pCR...